Regulatory T cell epitopes
AssigneesEpiVax, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services Food and Drug Administration
InventorsWilliam Martin, Amy S. Rosenberg
Life of this patent
Estimating the term…
Abstract
The present is directed to compositions comprising regulatory T cell epitopes, wherein said epitopes comprise a polypeptide comprising at least a portion of SEQ NOS: 1-14, fragments and/or variants thereof, as well as methods of producing and using the same.
Claims9
A method of inducing regulatory T-cells to suppress immune response in a subject comprising administrating to the subject a therapeutically effective amount of a T-cell epitope composition, wherein the T-cell epitope composition comprises one or more isolated T-cell epitope polypeptides, wherein at least one isolated T-cell epitope polypeptide consists of the amino acid sequence of SEQ ID NO:
- 1.
Dependencies are inferred from the claim text.